Biohm Technologies

Founded by Dr. Mahmoud Ghannoum, a leading microbiome researcher who coined the term "mycobiome," BIOHM Technologies emphasizes the critical role of fungi in human health. Leveraging over 40 years of research, the company provides advanced gut health solutions through their proprietary Symbiont™ discovery platform and clinically backed probiotic blends like Mycohsa™. 

Key Products and Services:

• Mycohsa™ Probiotic Blend: A comprehensive probiotic designed to address both bacterial and fungal communities in the gut. Clinically proven to break down digestive biofilms and support optimal levels of bacteria and yeasts for improved gut health. 
• Symbiont™ Discovery Platform: An AI-enhanced bioinformatics platform that utilizes BIOHM's extensive microbiome dataset to develop targeted microbiome-based products, including dietary supplements and functional foods. 
• Gut Health Test Kits: Private-labeled assessment tools that provide comprehensive analysis of both fungal and bacterial species in the gut, delivering actionable nutrition, lifestyle, and supplementation recommendations. 

Scientific Foundation:

BIOHM's innovations are built upon a vast microbiome dataset, one of the largest globally, and are supported by multiple human clinical trials and peer-reviewed publications. Their research-driven approach ensures the efficacy and safety of their products. 

Partnerships and Collaborations:

BIOHM collaborates with industry leaders to develop next-generation microbiome solutions. Notably, they have partnered with ADM® to create data-driven microbiome formulations targeting women's health. 

Contact Information:

• Address: 425 Literary Road, Suite 100, Cleveland, OH
• Website: biohmtechnologies.com

By integrating cutting-edge research with innovative product development, BIOHM Technologies is at the forefront of advancing gut health and overall well-being.